If you have emerging-market (EM) money to put to work, China and India are the two heavyweights — and they are not the same bet. China is the cheap, beaten-down value play; India is the premium-growth story. Most portfolios want some of both; the question is the split.
| Dimension | China | India |
|---|---|---|
| Valuation | Cheap — MSCI China ~10–12x forward earnings, well below its 10-yr average | Premium — often trades at a large multiple over China (discount estimates near ~40%) |
| Growth | 2026 EPS growth estimated ~10–15%; GDP target ~5% | Faster structural growth; 2026 EPS growth estimated higher, GDP ~8% in recent quarters |
| Thesis | Rerating + AI/industry-policy tailwind; "cheap does not stay cheap forever" | Demographics, infra, digitalisation; compounder story |
| Key risk | Policy/regulatory shifts, property weakness, deflation, geopolitics | High multiples leave little room for disappointment |
| Foreign access | US-listed/UCITS ETFs, ADRs, H-shares, Stock Connect A-shares | India ETFs (INDA, FLIN…) or global EM funds; direct stock access more restricted |
The two markets have even swung to a positive correlation at times, so they can rally together — driven by separate engines (Chinese domestic liquidity vs Indian earnings). That is why allocators often hold both rather than rotate fully between them.